To assess the long-term safety and efficacy of alcohol septal ablation (ASA) in young adults.
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Link betwen tako tsubo cardiomyopathy and major anxio-depressive disorders: a prospective study Clement Delmas [Orateur] (1), Olivier Lairez (1), Thomas Delmas (2), Attul Pathak (1), Meyer Elbaz (1), Didier Carrie (1), Michel Galinier (1), Jeroma Roncalli (1) (1) CHU Rangueil, Fédération des Services de Cardiologie, Toulouse Cedex, 
CEA-LETI, Département des Technologies pour la Biologie et la Santé, Grenoble, France
Background: Tako-tsubo cardiomyopathies (TTC) are usually associated with emotional or physics stress as aetiological factors. Nonetheless, exposition to stress does not unconditionally lead to TTC development. We hypothesize that TTC may occur in a predisposed population.
Purpose:
The aim of our prospective study was to define the prevalence of major anxiety troubles in a population of patients with TTC compared with a population of sex and age matched patients with acute coronary syndrome with troponin elevation (ACS).
Method:
Between January 2010 and March 2011, 35 patients with TTC confirmed by coronary angiography, cardiac MRI and clinical evolution were prospectively underwent to the psychiatric MINI test to research new or past major depressive episode (MDE), generalized anxiety trouble (GAT), posttraumatic stress state (PTSS) or dysthymia (DT). The same test was realized in a population of 30 matched patients with ACS.
Results: Mean age was 74 (65.5-82.5) Peripartum cardiomyopathy (PPCM) is frequent in Africa. It is characterized by heart failure in the last month of pregnancy or in the 5 months followings delivery. If the pathogenesis of the disease is still obscure the diagnostic has been greatly simplified by echocardiography showing typical appearance of hypokinetic cardiomyopathy, often dilated in a context of early heart failure occurred in the peripartum. However, manifestations of the disease are not unambiguous and changing parameters echocardiography has been little studied.
The aim of this work was to assess the echocardiographic abnormalities of the PPCM and to determine on 12 patients the evolution and the prognostic factors of this disease. The cases of peripartum cardiomyopathy treated from January 2008, to January 2011 in our service were reviewed. The abnormalities of the wall motion, constantly found, were diffuse in all patients and localized or prevalent on the interventricular septum or the left ventricular posterior wall in the other cases. The cardiac chambers were dilated in all patients. The left ventricular systolic dysfunction was constant. The other abnormalities were: restrictive mitral profil (6 patients) low mitral and aortic flow (3 cases), the mitral (10 cases) and tricuspid regurgitation (8). During follow up, all patients improved to Class I of NYHA, 2 patients improved their echocardiographic parameters and one patient died after a subsequent pregnancy.
The factors associated with the absence of normalization of the echocardiographic parameters were: the gestity, the parity, the cardiothoracic ratio, the left ventricular volumes, and the parameters of left ventricular function.
In conclusion, symptoms improve over time in a significant numbers of patients, which is corroborated by improvement of the LV function as assessed by echocardiography. Certain variables at initial evaluation can help in identifying high risk subsets with peripartum cardiomyopathy.
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Effects of permanent left atrial pacing in patients with heart failure and preserved ejection fraction Gabriel Laurent [Orateur] , Jean Christophe Eicher, Anaelle Mathe, Géral-dine Bertaux, Olivier Barthez, Clothilde Billard, Régine Debin-Duvernay, Fabien Garnier, Jean Eric Wolf CHU Bocage, Dijon, France Background: Although numerous patients are suffering from heart failure with preserved ejection fraction (HFPEF), no specific treatments have been shown to be efficient so far. We hypothesized that inter-atrial conduction delay (IACD) associated with a short left atrio-ventricular interval (LAVI) may impair left ventricular active filling as it reduces the left atrium "kick" which occurs against the closing mitral valve.
We assessed the clinical efficacy and safety of left atrial pacing therapy as a new treatment to restore the left ventricular active filling in these patients.
Methods: Six NYHA class III patients with severe HFPEF and no other cause for heart failure symptoms than a short LAVI with IACD were implanted with pacemakers for left atrial permanent stimulation via the coro-Archives of Cardiovascular Diseases Supplements (2012) 4, 30-41 nary sinus (lead screwed inside the Cs at 1 to 2 cm from the ostium). All patients were in sinus rhythm with an IACD defined as a p wave prolongation greater than 120ms in lead II, normal QRS interval. None of them had a standard indication for pacemaker implantation.
This double-blind, randomized, crossover study compared the responses of the patients during two periods: a two-week period of inactive pacing (ventricular inhibited pacing at a basic rate of 30 bpm) and a two-week period of active (left atrial permanent pacing). The primary end point was the distance walked in six minutes (6MWD). The secondary endpoint was the patient's treatment preference.
Results: During the inactive phase, two patients developed an acute heart failure few hours after the pacemaker was turned off. The mean (±SD) distance walked in six minutes was 21 percent greater with active pacing (237±30 m vs. 187±18 m, P<0.001). Active pacing was preferred by 100 percent of the patients.
Conclusions: Although the beneficial effects of left atrial permanent pacing need to be confirmed by a larger study, this new pacing strategy may improve exercise tolerance in patients with HFPEF and short left atrio-ventricular interval.
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Misclassified out of proportion post-capillary pulmonary hypertension associated with heart failure and preserved ejection fraction Introduction: Out of proportion post-capillary pulmonary hypertension (resulting from left-sided heart failure, group 2 of the World Health Organisation of Pulmonary Hypertension (PH) classification.) is a well known hemodynamic entity described in the past in mitral stenosis, but also concern patients with leftside heart failure and preserved ejection fraction (HFpEF). The prevalence is probably underestimated because a part of this population is addressed to the PH center and misdiagnosed group 1 PH of WHO classification.
Methods and results: From 2008 to 2011, we operate 1541 right heart catheterization and 454 were addressed form the PH center for evaluation. We identified 21 patients with out of proportion group 2 pulmonary hypertension and HFpEF. We determine the clinical, echographic and hemodynamic characteristics of these patients.
These patients are old (median =71 years, 67 to 77), more often female (15/21), with history of hypertension (20/21), mellitus diabete (14/21), obesity (16/21), atrial fibrillation (13/21), renal dysfunction (12/21) and a high prevalence of cardiovascular events.
In echocardiography, the ejection fraction is preserved (EF>50%), the systolic pulmonary arterial pressure is elevated (median=64 mmHg) and the right chambers are dilated (14/21) with elevation of the end-diastolic left side pressure and enlargement of the left atrial.
The right heart catheterization revise the diagnosis, sometimes only after filling test when capillary pulmonary (Pcap) is close to 15 mmHg. The PAPdPcap gradient (<10 mmHg) is more relevant (100% in our population) than the classic trans-pulmonary gradient to guide to the diagnosis of group 2 PH.
Conclusion:
There is concern that out of proportion post-capillary hypertension associated with HFpEF may often be misclassified as having WHO group 1 PH. The distinction is particularly important as therapies indicated in group 1 PH can be deleterious in group 2 PH.
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Heart failure with preserved ejection fraction -characteristics and prognosis -first results from the prospective KaRen study Erwan Donal [Orateur] (1), Lars H Lund (2), Cecilia Linde (2), Emmanuel Oger (3), Elodie Drouet (4), Jean-Claude Daubert (1) (1) CHU Rennes, Cardiologie, Rennes, Cardiology, Stokohlm, Université Rennes 1, Rennes, 
) SFC, Paris, France
Background: Heart failure with preserved ejection fraction (HFpEF) is equally common as reduced EF, but clinical characteristics and prognosis remain incompletely defined. There are differences in HFpEF definition and prognosis in clinical trials versus epidemiological surveys.
Methods:
The rationale for the multinational Karolinska-Rennes (KaRen) prospectiveobservational study has been desribed. Patients presenting with acute heart failure (HF) were screened in 14 university hospitals. Inclusion criteria were: Framingham criteria for HF and left ventricular EF-45%and NTproBNP > 300pg/ml. Once stabilized, 4-8 weeks after the index visit, patients were reevaluated and prospectively followed.
Results : Between 2007 and 2010, 478 patients were included. 42% were males. Female are older (78±9 vs 75±10, p=0.0009); faster (heart rate 87±55 vs 79±23, p=0.0001). Mean age was 77±16 years, body mass index 29±19 kg/m², left ventricular EF 56±14% (57±17 for female vs 55±17, p=0.001), and NTproBNP decreased from 3958±4534 to 2001±1949 pg/ml from inclusion to the 4-8 weeks visit (p<0.01), but 27% of the patients were still NYHA III to IV at second visit. Six-month mortality was 8%. Table I displays baseline characteristics.
Conclusion
In a prospective registry of HFPEF, patients are similar to that described in epidemiological studies, and mortality is similar to reduced EF. Patients are old, and remain symptomatic. Predictors of prognosis cause of death and targets of intervention will be presented. 
